Pharmaceutical Research Institute

The Pharmaceutical Research Institute (PRI) is a specialized research and development organization affiliated with the Albany College of Pharmacy and Health Sciences. PRI focuses on the discovery and development of novel therapeutic agents, particularly in the fields of oncology, vascular medicine, and ophthalmology. The institute is well-known for its work on thyroid hormone analogs (such as Tetrac and its nanoparticulate forms) and modified heparins that lack anticoagulant activity but retain anti-angiogenic and anti-inflammatory properties. PRI operates as a bridge between academic discovery and commercial drug development, often collaborating with industry partners to advance its proprietary pipeline.